Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development
Crossref DOI link: https://doi.org/10.1208/s12248-016-0030-z
Published Online: 2017-01-12
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Salazar-Fontana, Laura I.
Desai, Dharmesh D.
Khan, Tarik A.
Pillutla, Renuka C.
Prior, Sandra
Ramakrishnan, Radha
Schneider, Jennifer
Joseph, Alexandra
License valid from 2017-01-12